Achillion Presents at Wells Fargo 2013 Healthcare Conference

Achillion, an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease, announced in a news release that Milind Deshpande, President and CEO of Achillion, and members of the senior management team, will present a corporate update and participate on a HCV Panel at the Wells Fargo 2013 Healthcare Conference on June 18 in Boston, MA.  Achillion archives live audio broadcasts and webcasts of Company presentations on the Company’s website,, under the “News Center” section.